Literature DB >> 8566056

Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse.

F E Perry1, R N Barker, G Mazza, M J Day, A D Wells, C R Shen, A E Schofield, C J Elson.   

Abstract

Splenic T cells from Coombs'-positive New Zealand Black (NZB) mice proliferated consistently in vitro in response to the integral red blood cell (RBC) membrane protein Band 3, the antigen previously shown to be the target for the pathogenic RBC autoantibodies. The responding cells predominantly express CD4 and the proliferative response is blocked by antibodies to the NZB major histocompatibility complex class II but not by antibodies to an irrelevant H-2 haplotype. NZB splenic T cells also proliferated in response to the internal membrane skeleton protein spectrin. By contrast, T cells from BALB/c and DBA2 mice, which bear the same H-2 haplotype as NZB mice, but which do not develop autoimmune hemolytic anemia (AIHA), fail to respond to Band 3. It is considered that these results support the hypothesis that Band 3-reactive T cells provide help for the production of pathogenic anti-Band 3 autoantibodies in NZB mice. T cells from Coombs'-negative NZB mice as young as 3 weeks old proliferated in response to Band 3; moreover, the RBC from Coombs'-negative mice bore elevated levels of autoantibody as judged by a sensitive direct enzyme-linked anti-globulin test. Thus, the pathology of AIHA develops at a much earlier age than was thought previously.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566056     DOI: 10.1002/eji.1830260121

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Infection of C3HeB/FeJ mice with the docile strain of lymphocytic choriomeningitis virus induces autoantibodies specific for erythrocyte Band 3.

Authors:  G Mazza; M E el Idrissi; J P Coutelier; A Corato; C J Elson; C J Pfau; M J Day
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice.

Authors:  A-R Youssef; C-R Shen; C-L Lin; R N Barker; C J Elson
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

3.  Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide.

Authors:  C R Shen; D C Wraith; C J Elson
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

4.  Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia.

Authors:  R N Barker; R D Young; K A Leader; C J Elson
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

5.  B- and T-cell autoantigens in pristane-induced arthritis.

Authors:  R N Barker; A J Easterfield; R F Allen; A D Wells; C J Elson; S J Thompson
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

6.  T-helper 1 dominated responses to erythrocyte Band 3 in NZB mice.

Authors:  C R Shen; G Mazza; F E Perry; J T Beech; S J Thompson; A Corato; S Newton; R N Barker; C J Elson
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

7.  Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells.

Authors:  R N Barker; L-P Erwig; K S K Hill; A Devine; W P Pearce; A J Rees
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

8.  T-cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells.

Authors:  R N Barker; C-R Shen; C J Elson
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 9.  Autoimmune Hemolysis: A Journey through Time.

Authors:  John Freedman
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

10.  Induction of IL-10 cytokine and the suppression of T cell proliferation by specific peptides from red cell band 3 and in vivo effects of these peptides on autoimmune hemolytic anemia in NZB mice.

Authors:  Abdel-Rahman Youssef; Christopher J Elson
Journal:  Auto Immun Highlights       Date:  2017-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.